| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390500A1 Transgenic non-human animals for pharmacological and toxicological studies |
| 02/25/2004 | EP1390498A2 Gab2(p97) gene and methods of use thereof |
| 02/25/2004 | EP1390491A1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors |
| 02/25/2004 | EP1390483A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390384A2 Chromosome-based platforms |
| 02/25/2004 | EP1390060A2 Use of lp82 to treat body weight disorders |
| 02/25/2004 | CN2604055Y Maggot rearing materials separating device |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1477925A Method fr raising rabbits |
| 02/25/2004 | CN1476753A Artificial rearing method of eurysome golden thread leech |
| 02/25/2004 | CN1476752A Method for controlling cockroach by utilizing artificial propagation of tetrastichiclae |
| 02/25/2004 | CN1139600C Method for producing human milk ferritin utilizing transgenic animal milk gland |
| 02/24/2004 | US6696556 Genetic engineering |
| 02/24/2004 | US6696253 Method for determining the MHC genotype of chickens |
| 02/22/2004 | CA2399521A1 Insect rearing tray |
| 02/19/2004 | WO2004015417A1 A method and agents useful for same |
| 02/19/2004 | WO2004015123A1 Tissue specific expression of exogenous proteins in transgenic chickens |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015087A2 Eukaryotic genes involved in adult lifespan regulation |
| 02/19/2004 | WO2004015081A2 Methods for treating circadian rhythm phase disturbances |
| 02/19/2004 | WO2004015073A2 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015071A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004014131A1 KNOCKIN NONHUMAN ANIMAL AND TISSUE-SPECIFIC MnSOD-KNOCKOUT NONHUMAN ANIMAL |
| 02/19/2004 | WO2003087956A3 Robotic apparatus and methods for maintaining stocks of small organisms |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003053136A3 Triple transgenic mouse model of alzheimer's disease |
| 02/19/2004 | WO2003050265A3 Compositions and methods for normalizing assays |
| 02/19/2004 | WO2003048384A3 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms |
| 02/19/2004 | WO2003029454A3 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | US20040034882 Transgenic rodent with mutation in one allele of the corticotropin releasing factor receptor 2 protein for use as animal model in treating and diagnosing anxiety, depression, obesity and diabetes |
| 02/19/2004 | US20040034880 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools |
| 02/19/2004 | US20040034879 Mammalian sex selection using genetic modification |
| 02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/19/2004 | CA2495100A1 Tissue specific expression of exogenous proteins in transgenic chickens |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2494236A1 Csnk1gs as modifiers of the p21 pathway and methods of use |
| 02/19/2004 | CA2494066A1 Eukaryotic genes involved in adult lifespan regulation |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP0917423B1 Aquaculture of marine worms |
| 02/18/2004 | EP0765117B1 Biological control of insects |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | CN1475109A Boole goat fine tube seminal fluid freezing method |
| 02/17/2004 | US6693226 First model for tau pathology in alzheimer's disease |
| 02/17/2004 | US6692965 Exposing to molecular beacon comprised of nucleotides complementary to rna of interest; isolating cells that fluoresce upon hybridization |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6691638 Increasing the proportion of male chicks in chicken eggs by reducing the germ cells of female in ovo with busulfan, introducing male avian primordial germ cells into female bird in ovo; raising bird to maturity and breeding |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013171A2 Multi-subunit protein production system in transgenic insect |
| 02/12/2004 | WO2004012499A2 Method of selecting cells for somatic cell nuclear transfer |
| 02/12/2004 | WO2003097812A3 Transgenic ungulates capable of human antibody production |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003056022B1 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 02/12/2004 | WO2003053143A3 Method and apparatus for butane-enhanced aquatic plant and animal growth |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | US20040031070 RNA transfection of sperm cells |
| 02/12/2004 | US20040031069 Cloning endangered and extinct species |
| 02/12/2004 | US20040031068 A mammalian chimera comprising a non-human mammal transplanted with human endometrial cells or tissue which proliferate, form endometrial lesion |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040031066 The mice provide a new spontaneous model of human rheumatoid arthritis that will be useful for studying, testing new drugs and reagents for treating or diagnosing the disease |
| 02/12/2004 | US20040031065 Neuronal activation in a transgenic model |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040029800 Remedies for obesity and obesity-associated diseases and method of evaluating these remedies |
| 02/12/2004 | US20040029275 Short interfering RNA (siRNAs); reducing expression by obtaining and introducing into a cell multiple single or double stranded RNAs (dsRNAs) or DNA constructs capable of expressing multiple siRNAs in cells |
| 02/12/2004 | US20040029262 For the treatment of organic matter involving the use of worms to decompose organic material and produce castings |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029107 DNA sequence coding for bacteriophage recombinase; ligand-binding domain of steroid receptors; vectors |
| 02/12/2004 | US20040028719 Moderating dogs behavior |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028656 Survival of neurons |
| 02/12/2004 | CA2501415A1 Method of selecting cells for somatic cell nuclear transfer |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/10/2004 | US6689937 Transgenic mouse model of basal cell carcinoma |
| 02/10/2004 | US6689936 Administering compound to live transgenic mouse whose genome comprises dna sequence encoding luminescent or fluorescent reporter polypeptide coupled to vascular endothelial growth factor or versican promoter, evaluating expression in skin |
| 02/10/2004 | US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 02/10/2004 | US6689585 GABA-B2 receptor |
| 02/10/2004 | US6689583 Chromatin regulator genes |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6688255 Robotic apparatus and methods for maintaining stocks of small organisms |
| 02/05/2004 | WO2004011676A2 Multi-reporter gene model for toxicological screening |
| 02/05/2004 | WO2004011615A2 USES OF CIRCADIAN GENE mPER2 |
| 02/05/2004 | WO2004010776A2 Method and apparatus for conditioning honey bees |
| 02/05/2004 | WO2004010775A2 Honey bee monitoring system for monitoring bee colonies in a hive |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |